ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Inhibrx Biosciences Inc

Inhibrx Biosciences Inc (INBX)

15.00
0.00
(0.00%)
終了 12月4日 6:00AM
0.00
0.00
(0.00%)
取引時間後: -

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
15.00
買値
14.21
売値
15.50
出来高
-
0.00 日の範囲 0.00
10.80 52 週間の範囲 39.79
時価総額
前日終値
15.00
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
84,737
発行済株式数
14,475,904
配当利回り
-
PER
-1.40
1 株当たり利益 (EPS)
-10.71
歳入
1.63M
純利益
-154.96M

Inhibrx Biosciences Inc について

We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Inhibrx Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker INBX. The last closing price for Inhibrx Biosciences was US$15. Over the last year, Inhibrx Biosciences shares have traded in a share price range of US$ 10.80 to US$ 39.79.

Inhibrx Biosciences currently has 14,475,904 shares in issue. The market capitalisation of Inhibrx Biosciences is US$217.14 million. Inhibrx Biosciences has a price to earnings ratio (PE ratio) of -1.40.

INBX 最新ニュース

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results PR Newswire SAN DIEGO, Nov. 14, 2024 SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx...

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc...

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO, Aug. 13, 2024 SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- Inhibrx...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.66-4.2145593869715.6616.214.916057415.19722551CS
4-1.79-10.661107802316.7917.4112.258323314.88690675CS
12-0.5-3.2258064516115.517.7912.258473715.54903307CS
26-3.45-18.699186991918.4518.9510.812523814.99318866CS
52-7.49-33.303690529122.4939.7910.841032331.66360641CS
156-22.12-59.590517241437.1245.9897.6743012025.40910386CS
260-4.7-23.857868020319.750.977.6734616625.91117629CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AALAmerican Airlines Group Inc
US$ 14.47
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69.03
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.48
(0.00%)
0
AACGATA Creativity Global
US$ 0.9752
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 14.47
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69.03
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.48
(0.00%)
0
AACGATA Creativity Global
US$ 0.9752
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 14.47
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69.03
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.48
(0.00%)
0
AACGATA Creativity Global
US$ 0.9752
(0.00%)
0